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Measurements of lead in bone have recently become the focus of research because a) bone lead
levels serve as a cumulative dosimeter of lead exposure over many years (because of lead's long
residence time in bone), and cumulative exposure may be more predictive of chronic toxicity than
recent exposure, which is what blood lead levels mostly reflect; b) there is suspicion that
heightened bone turnover (e.g., during pregnancy, lactation, and aging) may liberate enough stored
lead to pose a significant threat of delayed toxicity; and c) although lead exposure has largely
declined in the United States over the past 10 to 15 years, decades of heavy environmental
pollution have resulted in significant accumulation of lead in bone among most members of the
general U.S. population. Epidemiologic research on the impact of lead stored in bone is now
possible with the development of 109Cd K-X-ray fluorescence (KXRF) instruments for the in vivo
measurement of lead in bone. In this paper, the KXRF method will be briefly reviewed, followed by
a summary of several Superfund-supported studies (and others) of blood lead and KXRF-measured
bone lead in which these measures are compared as biologic markers of lead dose. Measurement
of bone lead in epidemiologic studies has proved useful in exposure assessment studies, i.e., in
identifying factors that contribute most to retained body lead burden, and in investigating
cumulative lead exposure as a risk factor for poor health outcomes such as hypertension, kidney
impairment, cognitive impairment, behavioral disturbances, and adverse reproductive outcomes.
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Introduction
Monitoring and control ofexposure to lead
in the workplace, home, and community
has benefited tremendously from measur-
ing levels oflead in blood, a technique that
has been widely performed in laboratories
for this purpose for approximately 3
decades. Although early laboratory methods
suffered from problems with standardiza-
tion, precision, and the challenge ofcontrol-
ling the ever-present threat of external
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contamination, the advent ofanodic strip-
pingvoltametry, atomic absorption spectro-
scopy, clean laboratory techniques, and
external reference standards has greatly
improved the reliability and accuracy of
blood lead measurements. Such measure-
ments are now being widely performed in
laboratories throughout the world and form
the basis for the U.S. Centers for Disease
Control and Prevention recommendations
on the biologic monitoring ofchildren (1)
and the U.S. Occupational Safety and
Health Administration's recommendations
on the biologic monitoring ofworkers (2).
Blood lead levels, however, may not be
an adequate reflection of an individual's
full risk for lead-associated toxicity. This
concern is based on several realizations:
Lead accumulates in skeletal bone over
time, comprising 90 to 95% of lead bur-
den in adults and 80 to 95% in children;
(3,4) cumulative lead exposure may be
more predictive of some forms of chronic
toxicity than current lead exposure (5);
and although blood lead levels are generally
well correlated with current lead exposure,
they are poorly indicative oflead accumu-
lated in bone (6). Blood lead levels remain
constant when exposures are steady-state
while bone lead levels continue to rise, and
blood lead levels decline once exposure
ceases in the presence ofpersistently ele-
vated bone lead levels. Thus, following ces-
sation of exposure among chronically
exposed adults, blood lead levels have a
median biologic half-life ofabout 1 month
(range 7-63 days) (7,8), and therefore
mostly reflect recent lead exposure, whereas
bone lead levels, with a half-life ofyears to
decades, reflect accumulated exposure.
Finally, the growing appreciation of
bone as a dynamic organ throughout life
has heightened concern that lead stored in
bone can be mobilized into circulation,
providing a mechanism for delayed toxic-
ity. This phenomenon has been suggested
by a number of recent studies ofphysio-
logic states known to be accompanied by
elevated bone turnover, such as the rapid
growth of childhood (9), pregnancy
(10,11), lactation, and osteoporosis
(12,13), as well as a recent study of the
impact of hormone replacement therapy
on bone lead mobilization (14).
MeasuringLeadin Bone:
K-X-RayFluorescence
Until recently, epidemiologic research on
the implications oflead in bone has been
hampered by the lack ofa suitable noninva-
sive and convenient method for estimating
an individual's cumulative lead dose. Shed
primary teeth have been a reliable measure
oflead dose to mineralized tissue, but this
measure is suitable only for children and
only at certain ages, severely limiting its
application (15). The calcium disodium
edetate (EDTA) mobilization test requires
parental administration ofthe drug EDTA,
collection ofurine for hours to days, and
monitoring for drug toxicity. In addition,
the mobilizable fraction oflead measured
by this test probably differs from bone lead
levels, particularly among individuals whose
main lead exposure was years ago or who
have undergone chelation (16,17).
X-ray fluorescence (XRF) instruments,
which make in vivo measurements oflead
levels in bone, are quite promising in this
regard (18,19). Two types ofXRF instru-
ments exist-L-X-ray fluorescence (LXRF)
and K-X-ray fluorescence (KXRF). This
paper focuses on KXRF, which has been
the most widely used and validated
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technology. Discussion and critiques of
LXRF may be found elsewhere (20,21).
Most KXRF instruments use low-
intensity gamma radiation, emitted by a
'09Cd or 57Co 7-ray source, to provoke the
emission offluorescent photons from the
target area of a test subject's anatomy.
With specialized equipment, designs, sta-
tistical methods, and software, methods
have been developed to count these pho-
tons and derive estimates of bone lead
(in units ofmicrogram Pb/gram bone min-
eral) with ever-improving precision and
accuracy (22-24).
Our laboratory began a KXRF program
by working with a commercial company
(Abiomed, Inc., Danvers, MA) to develop a
'09Cd instrument that uses a 200-mCi
source in a 1640 backscatter geometry
(source-detector configuration) and is self
energy calibrating, automated, able to pro-
duce real-time results, usable on any site on
either lower limb, and operable by a techni-
cian (25). For our next generation ofinstru-
ments, we built our own instruments and
switched to a 30-mCi 109Cd spot-source
design and 1800 backscatter geometry
described first by Gordon et al. (23), and
then by us (24), while preserving most of
the ease-of-use features ofthe Abiomed
instrument. In summary, a '09Cd 1.11 GBq
(gigabecquerels) source ofactivity is sealed in
a stainless steel capsule housed in a tungsten-
alloy source holder. The 109Cd source is
positioned coaxial with and at the center of
the intrinsic Ge detector. The preamplifier
signal is passed to an amplifier and the ana-
log signal is converted into a digital signal
with a fast analog-to-digital converter and
then passed to a PC-based multichannel
analyzer board (Figure 1).
Asample spectrum is displayed in Figure
2. The net lead signal is determined after
subtraction of Compton background
counts, using a nonlinear least-squares fit
program first adopted and used by Chettle
et al. (22). The lead fluorescence signal is
then normalized to the elastic or coherently
scatteredX-raysignal, which arises predomi-
nantly from calcium present in bone min-
eral. The unit ofmeasurement so derived is
micrograms oflead per gram ofbone min-
eral. The instrument also provides an esti-
mate of uncertainty associated with each
measurement. The uncertainty element is
derived from a goodness-of-fit calculation
and counting statistics of the spectrum
curves. This value is equivalent to a single
standard deviation ifrepeated measurements
were taken. Thus, a typical measurement of
ToLN2tank
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tibia bone lead might be 17±3 pg/g. The
measurement uncertainty estimate allows a
more rigorous interpretation of each
measurement and can be used to weigh
each measurement as compared to other
measurements in the course ofdataanalysis.
By normalizing the measurement to
calcium counts, the measurement is ren-
dered insensitive to variations in bone
shape, size, density, histomorphometry,
overlying tissue thickness, and a small
amount of movement (26). Validation
studies with repeated measurements have
indicated the instrument provides a high
degree of precision and accuracy of the
point and measurement uncertainty esti-
mates as compared to chemical analyses of
lead-doped phantoms (24). Radiation
dosimetry studies measuring dose to skin,
bone red marrow, and the pelvic area have
demonstrated that a typical '09Cd KXRF
measurement gives extremely low effective
dose values of less than 0.1 pSv (27),
A
1,000,000 -
1-
o 1000-
Compton
-- peak
Kalpha-1 Elastic
X peak
/1 A
Kalpha-2
Kbeta-1,3 . 1
200 400 600 800
Channel no.
1000
Detectorbias
(dual HVsuppl
U)
0
C),
B
100,000-
10,000- ci1
Amplifier
I(spectroscopyAMP)
Anlog-todid"I
convn r
PC-basedniultichannel
analyer
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Figure 2. Sample spectrum of Harvard K-X-ray fluores-
cence. (A) Lead concentration 50 pg/g. Lead peaks are
mainly at the alpha-i and beta-1,3 areas. (B) Detail of
the alpha-i peak.
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significantly below a proposed limit of
negligibility of10 pSv (28).
The utility of KXRF-measured bone
lead in serving as a biologic marker is criti-
cally dependent on several concepts that
are common to all biologic markers and
laboratory measurements. Much additional
work, for example, has been done on cali-
bration procedures using lead-doped phan-
toms (24), and documentation ofprecision
and accuracy not only in phantoms, but
also in cadaveric specimens with verifica-
tion by atomic absorption spectroscopy or
inductively coupled plasma mass spectrom-
etry (26,29). In our laboratory, for exam-
ple, we found that the correlation of
measurements ofeight targeted cadaveric
tibias using our prototype KXRF instru-
ment in relation to atomic absorption spec-
troscopy measurements of the same sites
was 098 with an x intercept of-1 pg Pb/g
bone mineral over cadaveric bone lead con-
centrations ranging from 16 to 120 pg/g
(29). Gordon et al. (30) and Armstrong et
al. (31) demonstrated good reproducibility
of repeated KXRF measurements in low-
and high-lead-exposed adults, respectively.
Studies of intraskeletal variability of
lead concentration have also been per-
formed, thus verifying that bone lead con-
centrations vary significantly from site to
site, but in a consistent fashion (32,33).
Thus, single-site bone lead measurements
are fairly representative of total skeletal
burden. An important exception is that the
behavior oflead in bone seems to diverge
along the lines of the two main architec-
tural bone types-cortical bone and trabec-
ular bone. This probably stems from the
differing bone surface areas and bone
turnover rates ofthese two bone types. As a
consequence, some ofthe research groups
in this area have chosen to make KXRF
measurements at two separate sites (one
chiefly cortical and one chiefly trabecular)
for each individual. Chettle and colleagues
(22,34) have tended to use the midtibia
shaft and calcaneus as the cortical and tra-
becular bone sites, respectively, whereas we
have chosen the midtibia shaft and the
patella, respectively. We recently reported
on the difference between the tibia and
patella's rates of KXRF-measured bone
lead decline over 3 years ofrepeated obser-
vations among middle-aged to elderly men
from the general population (35). We
found that over this time interval the geo-
metric mean lead levels in the patella
declined by 23% (95% confidence interval
14-31%), whereas the geometric mean
lead levels in the tibia did not decline at all.
An important caveat related to KXRF
measurements is that their precision is
partially dependent on the mass of bone
that is being measured. Thus, the thin
bones ofchildren are measured with larger
error than the well-mineralized bones of
adults. Most studies have also indicated
that children tend to have lower bone lead
levels in general [e.g., Wittmers et al.
(32)]. Thus, the combination of lower
bone lead levels and larger measurement
error renders KXRF bone lead research in
children quite difficult.
Studies UsingKXRF:
xposure-Dose Relationships
By providing a biologic marker ofcumula-
tive dose, KXRF-measured bone lead can
be used in epidemiologic studies that
explore exposure-dose relationships and
provide information on those factors that
contribute most heavily to accumulated
lead burden, particularly in studies ofpopu-
lations in which lead exposure is occurring
through multiple possible pathways (as
opposed to studies ofindustrially exposed
workers in which the industrial lead expo-
sure predominates). A summary ofrelevant
studies is provided in Table 1. In an early
study using KXRF measurements offinger
bone lead, Price et al. (36) found that risk
factors for elevated bone lead were child-
hood residence in a painted wooden house
(probably exposure to lead paint) and vari-
ous occupational exposures. Similarly, we
found that growing up in older housing
(which probably reflects exposure to lead
paint) was asignificant predictor ofelevated
tibia bone lead level among young to mid-
dle-aged adults (29). Kosnett et al. (37)
found that total pack-years of cigarette
smoking and, among women, a history of
not having breast-fed an infant predicted
higher tibia bone lead levels. In construc-
tion workers who performed a variety of
activities with possible lead exposure, we
found welding/brazing, paint stripping,
carpet-laying, and exercise to be factors
associatedwith elevated bone lead (38).
In Superfund-supported research, we
studied a large group of community-
exposed middle-aged to elderly men living
in the metropolitan Boston, Massachusetts,
area, none of whom had held any jobs
associated with primary lead exposure (39).
In analyses that considered age, race, edu-
cation, retirement status, measures ofboth
current and cumulative smoking, and alco-
hol consumption, the factors that remained
significantly related to higher levels ofbone
lead were higher age, measures ofcumula-
tive smoking, and lower levels ofeducation
(39). Smoking entails lead exposure by a
direct contribution from tobacco (which is
contaminated by atmospheric lead deposi-
tion and lead arsenate pesticides) (40,41),
increased hand-to-mouth activity, and pos-
sibly the enhanced permeability of a
smoke-exposed respiratory tract (42).
Education may be serving as a proxy for
unmeasured cumulative environmental
exposures such as home exposure to lead in
dust and drinking water, home proximity
to vehicular traffic, and/or occupational
lead exposures.
The age-associated increases in bone
lead among nonoccupationally exposed
populations found in this study of Boston
area middle-aged to elderly men (39), and
in KXRF studies of Boston-area adoles-
cents (43), Boston-area young adults (29),
Boston-area women (44), Pennsylvania
residents (37), adults in Swansea, Wales
(45), and adults in southern Ontario,
Table 1. K-X-fay fluorescence research: risk factors for elevated bone lead levels in studies of environmentally
exposed populations.
Study population Riskfactors identified for higher bone lead Reference
Queensland adults Childhood residence in a painted wooden house Price et al. (36)
(lead paint), occupational exposures
Swansea adults Age Morgan et al. (45)
Boston-area adults Age, childhood residence in a house built prior Hu et al. (29)
to 1955(lead paint)
Pennsylvania adults Age, cumulative smoking, no breast-feeding Kosnett et al. (37)
Construction workers Age, welding/brazing, carpet laying, paint Watanabe et al. (38)
stripping, lack of exercise
Boston-area adolescents Age Hoppin et al. (43)
Boston-area elderly men Age, cumulative smoking, lower education Hu et al. (39)
Boston-area young women Age Hu et al. (44)
Mexico Citywomen Years living in Mexico City, lowerdietary calcium Hernandez-Avila et al. (49)
Boston-area elderly men Age, cumulative smoking, lowereducation, Cheng et al. (51)
lower dietaryVitamin D, lower dietary iron
Mexico City adolescents Higher traffic density near home, smoking by Farias et al. (50)
subject's mother, time spent outdoors
Environmental Health Perspectives * Vol 106, Supplement 4 * August 1998 963H. HU
Canada (46), parallels the age-associated
increases in chemically measured bone lead
levels found in autopsy studies (32,47),
suggesting perhaps that bone lead rises
inexorably with aging. However, because
these trends were found in cross-sectional
epidemiologic studies, an alternative expla-
nation is that this represents a cohort
effect, i.e., older individuals were exposed
to more lead when they were as young as
the younger individuals in this study.
Indeed, in a 3-year follow-up study ofbone
lead levels in the Boston-area middle-aged
and elderly men, bone lead (particularly in
the patella, a trabecular bone) was uni-
formly declining over time (35), probably
reflecting the gradual replacement ofbone
rich in lead (from higher earlier exposures)
with bone relatively low in lead content
(48). In cross-sectional studies ofMexican
women (49) and adolescents (50), bone
lead levels were not higher in older individ-
uals, probably reflecting a historical trend
in lead exposure that is different from that
ofthe United States.
The development ofrelatively reliable
and accurate semiquantitative food fre-
quency questionnaires has also allowed
studies of nutritional factors that may
influence lead burden. In a further study of
our cohort of Boston-area middle-aged to
elderly men, we found that higher bone
(but not blood) lead levels were predicted
by low dietary levels ofvitamin D even
after adjusting for age, education, smoking,
and alcohol consumption (51). This effect
appeared to have a threshold around the
lowest quintile ofvitamin D consumption,
above which bone lead levels did not vary
greatly. Low dietary calcium was also pre-
dictive ofhigher bone lead, but the effect
was not as strong as that ofvitamin D. In a
study of peripartum women living in
Mexico City, we found that predictors of
higher bone lead included time spent living
in Mexico City (as opposed to rural
Mexico, probably reflecting exposure to air
pollution in Mexico City), and lower
dietary intake levels of calcium supple-
ments, milk, and cheese (49). These effects
may reflect the impact of diet on lead
absorption as well as lead kinetics.
Studies UsingKXRF:
Dose-Disease Relationships
Of most interest to epidemiologists
interested in risks associated with disease is
bone lead's ability to serve as a biologic
marker ofdose and the additional informa-
tion it provides, if any, beyond that
provided by blood lead levels. A summary
Table 2. K-X-ray fluorescence research: bone lead as a riskfactorforadverse health outcomes.
Study population
Lead smelters
Adolescents
Construction workers
Lead smelterworkers
Adolescents
Elderly men
Adult men
Elderly men
Nurses
Postpartum women
Outcome studied Findings
Kidneydysfunction
Neuropsychologic
tests
Hemoglobin, serum
creatinine, blood
pressure
Kidneydysfunction
Behavior
Hypertension
Cognitive tests
Cognitive tests
Hypertension
Infant birthweight
of relevant studies is provided in Table 2.
Published occupational studies using
KXRF have tended to focus on levels of
bone and blood lead as predictors ofkid-
ney disease and urinary biomarkers of risk
ofkidney dysfunction. Ofthese, no consis-
tent relationships have been found so far
(52,53). On the other hand, several signifi-
cant bone lead-disease relationships have
been found in cross-sectional studies that
focused on other health outcomes and used
larger sample sizes and more moderately
exposed subjects. Among adolescents who
participated in a long-running cohort
study, higher bone lead level correlated
with some measures ofworse performance
on a neuropsychologic test battery, but its
influence was not as great as that of the
lead levels in deciduous teeth theyhad shed
when young (54). Among 12-year-old
boys in public school, Needleman et al.
(55) found that rising tibia bone lead levels
were associated with increased parental and
teacher reports of delinquent, aggressive,
internalizing, and externalizing behavior.
In a study ofmoderately lead-exposed con-
struction workers, we found that the
patella (trabecular bone) is associated with
significantly lower hematocrit and hemo-
globin values, even after adjustment for
age, smoking, and alcohol ingestion (56).
In our Superfund-supported study of
middle-aged to elderly men with commu-
nity exposures to lead, bone lead (but not
blood lead) was significantly related to
increased odds ofclinically relevant hyper-
tension, even after adjustment for age,
smoking, alcohol ingestion, family history
ofhypertension, body mass index, dietary
calcium, and dietary sodium (57). Age was
associated with significantly higher odds of
the occurrence ofhypertension in analyses
No relationship
Marginal relationship; not as
good a predictor as dentin lead
Significant decline in hemoglobin
with higher bone lead
Hyperfiltration
Increased delinquent, aggressive,
internalizing, and externalizing
behaviorwith higher bone lead
Increased riskwith higher bone lead
Poorer performance with higher bone lead
Poorer performance with higher bone lead
Increased with higher bone lead
Significant decline with higher bone lead
Reference
Gerhardsson etal. (52)
Bellinger et al.(54)
Huetal.(56)
Roels et al. (53)
Needleman et al. (55)
Hu etal. (57)
Bleecker etal. (62)
Payton et al. (61)
Korrick etal. (59)
Gonzalez-Cossio
et al. (63)
excluding bone lead; however, the effect
of age decreased markedly and was not
statistically significant in models that
included bone lead. Our finding raises the
issue of whether lack of environmental
lead exposure is at least partly responsible
for the lack of an age-associated increase
in blood pressure and hypertension
among nonindustrialized societies (58).
Subsequently, in a case-control study
among Boston-area nurses, we found that
bone lead, but not blood lead, was signifi-
candy related to increased odds ofhyperten-
sion, even after adjustment for age, intake of
dietarycalcium, sodium, and alcohol, smok-
ing, body mass index, and family history of
hypertension (59). The findings ofthese two
studies on bone lead and hypertension may
explain why many ofthe previous studies of
blood (not bone) lead and blood pressure
have been negative or equivocal (60).
Among middle-aged to elderly men,
higher bone lead also correlated with worse
performance on specific cognitive tests
(61). In this study, higher blood lead levels
correlated better than bone lead levels for
some outcomes, whereas higher bone lead
levels correlated better than blood lead lev-
els with other outcomes (e.g., spatial copy-
ing and pattern memory). Similar patterns
were found in a recent investigation by
Bleecker et al. (62) utilizing blood and
bone lead levels.
In our Superfund study of lead and
reproduction among women giving birth
in Mexico City, we found that bone lead,
but not blood lead, was significantly
related to decreased birth weight, even after
adjustment for maternal age, maternal arm
circumference and height, smoking, parity,
history ofadverse reproductive outcomes,
education, infant gender, and gestational
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age (64). This finding is particularly
noteworthy because birth weight cannot be
considered a chronic disease outcome;
thus, it is less likely that bone lead is simply
serving as a proxy for cumulative lead
exposure, and more likely that bone lead is
itself being mobilized (from the increased
bone turnover associated with pregnancy)
and causing acute toxicity to the fetus.
Bone lead can also be compared with
environmental determinants as influences
on blood lead levels. In this regard, we
found that bone lead retained a major
influence on blood lead levels among peri-
partum mothers in Mexico City, even after
adjusting for current use of lead-glazed
ceramics, smoking, age, occupation, years
ofeducation, parity, and years ofliving in
Mexico City (49). Bone leadwas also a sig-
nificant influence on blood lead among
Mexico City adolescents (50). Among
middle-aged to elderly men, most ofwhom
were retired, bone lead was the overwhelm-
ingly predominant determinant ofblood
lead variance (39).
These types ofstudies support bone lead
as a major internal source ofcirculating lead
levels, particularly among individuals whose
current environmental exposures have
declined. They are complemented by KXRF
studies ofoccupationally exposed workers.
Gerhardsson et al. (64), for example,
demonstrated a higher correlation between
bone lead and blood lead among retired, as
opposed to active, lead workers (64).
Nilsson et al. (8) reported longitudinal data
demonstrating a triexponential decay curve
in blood lead dedine following cessation of
lead exposure, the slow phase ofwhich
clearly parallels the slow decline oflead in
bone. Fleming et al. (65) found similar
decay patterns in a KXRF investigation of
lead smelter employees.
Conclusions
Although lead has been arguably the most
studied toxin in environmental health,
many unknowns still exist, particularly with
regard to its potential to cause long-term or
delayed toxicity. The development of
KXRF methods for the in vivo measure-
ment of bone lead levels has begun to
enhance our ability to study this issue and
the related issue as to whether mobilization
oflead stored in bone may pose a signifi-
cant delayed threat. Should bone lead
mobilization be identified as an important
risk, identifying factors that influence bone
turnover, and therefore release oflead from
bone, may be important in identifying
strategies for mitigating the toxic effects of
lead accumulated from historical exposures.
Through its ability to serve as a cumula-
tive dosimeter, bone lead levels may also be
useful in dose reconstruction studies, partic-
ularly in populations in which historical
environmental or blood lead data are lack-
ing. Initial studies on exposure-dose rela-
tionships have already demonstrated the
utility ofmeasuring bone lead as a means of
identifying demographic and lifestyle factors
that influencelead accumulation.
At some point in the future, ifKXRF-
measured bone lead is confirmed as a
predictor of disease, intervention studies
might be considered. It is possible, for
example, that new chelating agents orstrate-
gies for inhibiting bone lead mobilization or
lead-enzyme interactions may delay or
reverse the progression ofbone lead-associ-
ated disease. Successful interventions would
warrant consideration ofusing KXRF, at
some point, as a screening tool for certain
groups ofindividuals at high risk.
However, large-scale screening, as is
currently undertaken for potentially lead-
exposed workers using blood lead levels,
would be unlikely given the need for each
test subject to visit a KXRF laboratory for
30 to 60 min ofmeasurements conducted
by a trained technician. In addition,
although semiautomated instruments can
be purchased, existing KXRF laboratories
currently number fewer than 10 world-
wide, are mostly oriented toward research,
and require a trained physicist for set-up,
calibration, and quality control in each lab-
oratory. Finally, as noted previously,
KXRF measurements in children, as com-
pared to adults, have poor precision. Data
on accumulation oflead in the bones of
children are greatly needed, however, pos-
ing a challenge to researchers in this area to
further improve the technical capabilities
ofKXRF instrumentation.
Much additional research needs to be
done, and investigators in this area are
grateful for the support being given for
these efforts by the National Institute of
Environmental Health Sciences Superfund
Basic Research Program.
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